North America currently leads the DNA Synthesis Market due to its mature biotech ecosystem, heavy investment in genomics, and ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. DNA synthesis is vital to several processes in biopharmaceutical innovation, including the ...

Ansa Biotechnologies hauled in a total of $54.4 million in an oversubscribed series B round of financing that will be used to expand the company’s DNA synthesis production capacity in the U.S. The San ...

There’s an old saying about a dollar waiting on a dime. In other words, a monumental endeavor may become stuck at some point if a key preliminary element remains unavailable. The saying could be ...

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...

The Non-NGS Predictive Cancer Diagnostics Market is entering a high-growth decade, driven by precision oncology expansion, early cancer detection priorities, and automation in laboratory workflows.

DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...

The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome ...